DVT Treatment in Singapore: Medicines and Selected Procedures

Treatment for deep vein thrombosis (DVT) aims to limit clot growth, reduce the risk of pulmonary embolism and manage symptoms. Anticoagulant medicines are the main treatment for many patients. Removing a clot is considered in selected circumstances; it is not routinely required for every DVT.

New one-sided leg swelling or pain needs urgent assessment. Sudden breathlessness, chest pain, coughing blood, fainting or collapse may indicate pulmonary embolism (PE). Seek emergency assessment and call 995 in Singapore for life-threatening symptoms. Do not wait for a routine appointment.

What determines the treatment plan?

The team considers where the clot is, how extensive it is, symptom duration, circulation and bleeding risk. Ultrasound commonly establishes the location; further imaging may be needed for pelvic veins or another clinical question. Previous clots, cancer, pregnancy, kidney function, medicines and recent procedures can change the plan.

How do blood-thinning medicines help?

Anticoagulants reduce further clotting while the body gradually deals with the existing clot. They do not physically extract it. The medicine and treatment setting are selected individually. For selected clots confined to calf veins, a clinician may recommend structured ultrasound surveillance rather than immediate anticoagulation, based on symptoms and extension risk.

For many treated DVTs, an initial course lasts three to six months, followed by an individual decision about stopping or continuing. Feeling better is not a reason to stop independently. Check before adding medicines or supplements, and tell other healthcare professionals about anticoagulation. Significant bleeding needs urgent assessment; a head injury while taking an anticoagulant warrants prompt emergency-department assessment even if you feel well.

When is catheter-directed thrombolysis considered?

Thrombolysis uses clot-dissolving medicine delivered through a catheter. It may be considered for selected recent, severely symptomatic iliofemoral DVT, involving the pelvic veins or the common femoral vein near the groin, when bleeding risk is low and expected benefit justifies treatment. Early clot removal is generally not recommended for DVT confined to the femoral, popliteal or calf veins. A threatened leg, with rapidly worsening severe swelling, pain or colour change, requires emergency care.

Major bleeding, including bleeding in the brain, is an important risk. Treatment is undertaken in an appropriate hospital setting with monitoring. It is not simply a stronger version of a routine blood thinner.

What is mechanical thrombectomy?

Mechanical thrombectomy uses a catheter-based device to remove clot. It may be used alone or with clot-dissolving treatment in selected patients. Avoiding a thrombolytic drug does not eliminate bleeding or other risks: vessel injury, blood loss, embolisation, contrast-related problems and recurrent thrombosis may occur.

The decision considers anatomy, clot age, symptoms and the limitations of the evidence. It cannot promise normal long-term vein function or freedom from post-thrombotic syndrome. Dr Choong’s video article on modern clot removal explains why selection matters.

When might an iliac venous stent help?

A significant pelvic-vein narrowing or obstruction can sometimes contribute to impaired drainage. After suitable assessment, a stent may be discussed in selected acute or chronic cases. An incidental compression seen on a scan is not, by itself, an indication.

Stents can block, narrow again or require further intervention. Treatment entails a medication and surveillance plan; inserting a stent does not automatically remove the need for anticoagulation.

What is the limited role of an IVC filter?

An inferior vena cava filter can catch some clots travelling towards the lungs. It does not treat the leg clot. It may be considered when anticoagulation cannot be given, or in selected cases of PE despite treatment after the reasons for treatment failure have been investigated.

Filters are not routinely added when anticoagulation is working. They can cause thrombosis, move, fracture or become difficult to retrieve. If a retrievable filter is used, the plan should include follow-up and removal when protection is no longer needed and removal is appropriate.

What follow-up matters?

Review covers medication safety, recurrence risk, activity and persistent symptoms. Compression may help some swelling or discomfort but does not replace anticoagulation or guarantee prevention of post-thrombotic syndrome. Return to work, exercise and travel needs individual advice.

Persistent heaviness, swelling, skin changes or ulcers deserve assessment. New worsening symptoms should be checked sooner than a scheduled review. PE treatment is coordinated by the hospital team according to severity; a leg-vein clot-removal discussion does not establish a need for a lung-artery procedure.

Common questions

Will a procedure let me stop blood thinners?

Not necessarily. The medication plan depends on the clot and continuing risks, including after successful removal or stenting.

What should I bring to a planned review?

Bring discharge letters, scan reports, medication details and any procedure or filter records. For non-emergency follow-up, contact Andrew Choong Vascular Surgery, Mount Elizabeth Novena Specialist Centre, #09-22, 38 Irrawaddy Road, Singapore 329563.